2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Oral Arsenic (ATO) in Low-risk Myelodysplastic Syndromes (MDS)Low-risk Myelodysplastic SyndromesRecruitingPhase 12026-09-10NCT06670222
Momelotinib in VEXAS SyndromeHemic and Lymphatic Diseases, VEXAS syndrome, bone marrow disorder, hematologic disorder, myelodysplastic syndromeRecruitingPhase 22026-08-10NCT07098936